Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Novartis
Novartis
Flamel Shares Flamed Out: What You Need to Know
Motley Fool
Thu, 12/15/11 - 07:11 pm
Flamel
GSK
Novartis
Emisphere
2012 Preview: Cancer Immunotherapy Catalysts
Seeking Alpha
Thu, 12/15/11 - 12:08 pm
cancer
Antigenics
Amgen
Bristol-Myers Squibb
Celgene
Dendreon
Generex
Merck KGaA
GSK
Idera Pharmaceuticals
NewLink Genetics
Novartis
Roche
Oncothyreon
Transgene
Vical
Gilenya trial could ease safety worries
Baltimore Sun, MD
Thu, 12/15/11 - 11:35 am
MS
multiple sclerosis
Gilenya
Novartis
Sanofi Accused Of Anticompetitive Vaccine Pricing
Pharmalot
Wed, 12/14/11 - 10:56 am
Sanofi
vaccines
drug pricing
Novartis
Menveo
Menactra
N.C. Novartis Site Is First Cell-Based Flu Vaccine Facility in the Country
Motley Fool
Tue, 12/13/11 - 11:07 am
North Carolina
Novartis
flu vaccines
drug manufacturing
Disclosed: SIGA Technologies Receives $36M Payment From HHS
Seeking Alpha
Tue, 12/13/11 - 09:24 am
SIGA technologies
HHS
Abbott Laboratories
GSK
Novartis
PharmAthene
Novartis Probes Death Tied To New MS Pill
Pharmalot
Mon, 12/12/11 - 12:48 pm
Novartis
MS
multiple sclerosis
Gilenya
Attention Deficit Drugs Don’t Raise Adults’ Heart Risk in Study
Bloomberg
Mon, 12/12/11 - 11:47 am
Shire
Ritalin
Novartis
JNJ
Concerta
ADHD
Adderall
ADD
Big promise is seen in 2 new breast cancer drugs
Yahoo/AP
Wed, 12/7/11 - 10:13 pm
breast cancer
Genentech
Pertuzumab
Afinitor
Novartis
FDA Warns Novartis on 3 Manufacturing Facility Sites
Pharma Live
Wed, 12/7/11 - 11:47 am
Novartis
warnings
FDA
drug manufacturing
Novartis MS Pill Gilenya Rejected by U.K. Health-Cost Agency
Bloomberg
Wed, 11/30/11 - 07:42 pm
Novartis
MS
multiple sclerosis
Gilenya
Novartis’s Lucentis Fails to Win Backing in Final U.K. Guidance
Bloomberg Businessweek
Wed, 11/30/11 - 09:30 am
Novartis
Lucentis
UK
diabetic macular edema
Novartis receives European approval for blood pressure pill Rasitrio
Yahoo/AP
Mon, 11/28/11 - 09:54 am
Novartis
Europe
antihypertensives
Rasitrio
Lipid Signaling Could Shake Up Biotech In 2012 With Pending Lpath And Peregrine Trial Data
Seeking Alpha
Tue, 11/22/11 - 11:57 am
Lpath
lipid signaling
Peregrine Pharmaceuticals
Novartis
Pfizer
Biogen Idec
Bet On The Biotech Sector: The War On Neurodegenerative Disease
Seeking Alpha
Tue, 11/22/11 - 10:58 am
neurodegenerative disease
Sanofi
Valeant Pharmaceuticals
Novartis
Zelapar
Comtan
Parkinson's Disease
Novartis Execs, Cover-Ups And Jawbone Damage
Pharmalot
Tue, 11/22/11 - 09:41 am
Novartis
Zometa
Aredia
Mylan to sell generic version of Vivelle-Dot
Bizjournals.com
Mon, 11/21/11 - 09:42 am
Mylan
generics
Vivelle-Dot
menopause
estrogen patch
Novartis
Achillion in Talks With Potential Buyers or Partners, Chief Executive Says
Bloomberg
Sat, 11/19/11 - 11:35 am
Achillion
hepatitis C
GSK
Novartis
Novartis Pays $150M To Settle Pricing Fraud
Pharmalot
Fri, 11/18/11 - 11:48 am
Novartis
pricing
fraud
settlements
Sandoz
Medicaid
Intellipharmaceutics: A Deep Value Opportunity In Generics And Specialty Pharmaceuticals
Seeking Alpha
Fri, 11/18/11 - 11:42 am
Intellipharmaceutics
generics
Pfizer
AstraZeneca
Novartis
Bristol-Myers Squibb
Pages
« first
‹ previous
…
126
127
128
129
130
131
132
133
134
…
next ›
last »